GKB Ophthalmics share news and announcements
NSE: GKBBSE: 533212Healthcare Equipment & SuppliesSmall Cap
Last close ₹59.54up ₹0.93 (1.59%)BSE ₹64.97
Share price at the NSE close on 23 Oct 2026. Previous close ₹58.61.
52-week range of BSE trades to 23 Oct 2026
₹45.25Low, 5 Dec 2025₹76.90High, 15 Apr 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹30 Cr3,821st largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 12 Aug 2026
- 9.3
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 6.3
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 27 May 2026
- 0.6
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 12 Aug 2026
- 6.2%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹1.49 crore of one-off items, the largest of them in the quarter to Mar 2026.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 12 Aug 2026
- 10.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 27 May 2026
- 0.21
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 2,45587.1% delivered
GKB Ophthalmics share news and announcements
995 announcements, routine notices left out, newest first. Page 16 of 20.
Oct 2013
Sep 2013
Aug 2013
Jul 2013
29 Jul · Board meeting
Inter alia, to consider and take on record the Un-audited Financial Results of the Company for the quarter ended 30th June 2013. (Source MSE)
Jun 2013
13 Jun · Meeting
The 31st Annual General Meeting of the Company will be held on 31st August 2013 and the Share Transfer books and the Register of Members of the Company will remain closed from 23rd August 2013 to 31st August 2013 (both days inclusive) (Source MSE)13 Jun · Meeting
AGM/Book Closure11 Jun · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from August 23, 2013 to August 31, 2013 (both days inclusive) ....
May 2013
31 May · Dividend
Board of Directors of the company at their meeting held on 28th May 2013 has decided to pass over the dividend for the year 2012-13. (Source MSE)31 May · Dividend
Dividend29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2013, inter alia, has decided the following : 1. To pass over the dividend ....29 May · Management
23 May · Board Meeting Postponed on May 28, 2013
With reference to the earlier announcement dated May 02, 2013 regarding Board to consider Dividend, GKB Ophthalmics Ltd has now informed BSE that the Meeting of the Board of Directors scheduled ....22 May · Board meeting
Meeting of the Board of Directors scheduled on 24th May 2013, for approval of Audited Results has been Postponed. The revised date of the Board Meeting is 28th May 2013. (Source MSE)22 May · Management
An Additional Independent Director is expected to be inducted in the forthcoming Board of Directors' Meeting to be held on 24th May 2013. (Source MSE)22 May · Gkb Ophthalmics Limited has informed the Exchange that an Additional Independent Director is expected to be inducted in the forthcoming Board of Directors' Meeting to be held on 24th May 2013. (Source MSE)
Appointment of Director2 May · Board meeting
Meeting of the Board of Directors of the Company will be held on May 24, 2013, to consider and approve the Audited Financial Results of the Company ....2 May · Board meeting
To consider and approve the Audited Financial Results of the Company for the year ended 31st March 2013 and to recommend dividend, if any. (Source MSE)
Apr 2013
8 Apr · Updates
Company has opted to submit the Audited Results for the year ended 31st March 2013 on or before 30th May 2013. (Source MSE)8 Apr · Results
Updates